Guidelines for Authors
www.karger.com/res_guidelines
 Submission
Conditions
Sections
E-pub First
Arrangement
Color Illustrations
References
SI Units
Digital Object Identifier (DOI)
Author's ChoiceTM, NIH-Funded Research, Self-Archiving
Page Charges
Proofs
Reprints
Financial Disclosure and Conflicts of Interest
Further Information
Submission
Manuscripts written in English should be submitted online:
or as an e-mail attachment (the preferred word-processing package is MS-Word)
to the Editorial Office: res@karger.ch
Editorial Office 'Respiration'
S. KARGER AG
P.O. Box
CH–4009 Basel (Switzerland)
Tel. +41 61 306 1357
Fax +41 61 306 1434
All manuscripts must be accompanied by a covering letter signed by all authors. Assurance should be given that the manuscript is not under simultaneous consideration by any other publication. The preferred word processing package is Word for Windows®. Presentation of manuscripts should conform with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see N Engl J Med 1997;336:309–315).
Conditions
All manuscripts are subject to an editorial process involving the Editor-in-Chief, an Associate Editor and reviewers. Notification can be expected within two months from the date of receipt. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of ‘Respiration’ and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author’s responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
Clinical Trials: In accordance with the recommendations of the International Committee of Medical Journal Editors, the journal requires that all clinical trials having commenced on or after 1 July 2005 be registered in a public trial registry accessible free of charge. Please consult http://www.icmje.org/index.html#clin_trials for further details. The journal consists of the following sections:
Sections
The journal consists of the following sections:
1. Thematic Review Series
2. Editorials
3. Clinical Investigations
4. Interventional Pulmonology
5. Basic Science Investigations
6. New Drugs in Respiratory Medicine
7. Technical Notes
8. The Eye Catcher
9. Novel Insights from Clinical Practice
10. What Is Your Diagnosis?
11. Reviews
12. The Opinion Corner
13. Clinico-Pathological Conferences
14. Letters to the Editor
15. Congress Calendar
Reviews: Invited reviews, if accepted, are not subject to page charges. Unsolicited reviews may also be submitted for consideration.
Letters addressed to the Editor are encouraged if they directly concern articles previously published in this journal and clinical subjects related to the matters discussed. The editor reserves the right to submit copies of such letters to the authors of the articles concerned prior to publication in order to permit them to respond in the same issue of the journal. But letters on general scientific or medical subjects in respiratory medicine are also welcome. Letters to the Editor should be no longer than one printed page.
Eye Catchers: Maximum 1 printed page. Text may not exceed 250 words to allow sufficient space for pictorial material, which is the main object of an Eye Catcher. Maximum 2 references and 2–5 keywords.
Novel Insights from Clinical Practice (formerly Case Reports): Maximum 7 authors. The publication space available for case reports is very limited. The journal only considers case reports with significant new insights or with an extremely unusual and memorable course. Highlighted boxes containing one or two bullet points on ‚Established facts‘ (what is already known) and ‚Novel insights‘ (what new information has been gained) are required and should be placed on the first page of the report. These should be selected so as to reinforce the novelty of the clinical observation. The text per box should be limited to 1–2 very short sentences. The manuscript should be presented with an abstract (unstructured, max. 200 words), followed by introduction, case report and discussion. Maximum 3 figures.
What Is Your Diagnosis?: Select catchy title not disclosing the diagnosis. Page 1: Case report and 1–2 illustrations and the question 'What Is Your Diagnosis'. Page 2: The diagnosis followed by a short description of what diagnostic procedures were done to reach the diagnosis and the discussion with references. Maximum 15 references and include 3–5 keywords.
Patient Consent: This is required for ALL articles containing personal information about the patient submitted for publication in the following sections:
Novel Insights from Clinical Practice
What Is Your Diagnosis?
Eye Catcher
Signed patient consent must be obtained from the patient, guardian or next of kin (or a statement that the patient was not alive at the time of writing) and submitted along with the manuscript.
E-pub First
All articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference of the printed version. The articles become available immediately after the authors' approval to print, with the added advantage of being citable much earlier than previously. Authors can influence the time of appearance by promptly returning the proofs.
Arrangement
Pages should be numbered throughout the manuscript text.
Title page: The first page of each paper should indicate the title, the authors’ names, the institute where the work was conducted, and a short title for use as running head.
NB: Authors wishing to preserve the phonetic meaning of diacritics (PubMed reduces diacritics to their root characters) must spell their names accordingly when submitting manuscripts (e.g. Müller should be Mueller).
Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.
Key words: For indexing purposes, a list of 3–7 key words is essential.
Abstract: Each paper needs an abstract of up to 250 words. Abstracts of papers submitted for publication in the sections Clinical Investigations, Basic Science Investigations, Interventional Pulmonology, and Technical Notes should be structured as follows:
Background: What is the major motive that prompted the study?
Objectives: What is the purpose of the study?
Methods: How was the study done?
Results: Most important findings.
Conclusions: Most important conclusions.
Introduction: What is the main question? State your considerations leading to the formulation of this question.
Material and Methods: Prior approval of an Institutional Review Board (IRB) is required for all investigations involving human subjects and animals. Animal experimentation must be performed according to the Helsinki Declaration.
Study design: Provide a short survey of the tests or experiments. Include the independent variable(s) manipulated, the dependent variable(s) measured and all controls.
Methods: Describe methods and apparatus in detail. Provide references and brief description of methods already published. Identify drugs and chemicals, including generic name, dosage and administration. Describe the pre-study condition of patients or animals.
Analysis: Define the variables. Use statistical analysis that is appropriate for the study. Describe statistical methods used for each analysis; provide references for tests that are not well known.
Results: A concise report of important results only. Use figures and tables for the presentation of data; summarize the most important observations in the text.
Discussion: Summarize main results and make sure you can answer the question asked in the introduction, briefly supporting the answer with the relevant results. Explain and defend the answer, comment on contradictory or unexpected results and discrepancies with previous findings. Elaborate on new and important aspects of the study.
Acknowledgements: Use this section to name persons who have contributed to the article, but whose contributions do not justify authorship.
Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.
SI Units: Since the United States of America and other countries outside of Europe where ‘Respiration’ is read have not accepted the SI system, authors using SI units should add the conventional units in brackets:
e.g. pO2 = 10 kPa (75 mm Hg).
Tables and Illustrations:
Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate sheets. Tables require a heading and figures a legend, also prepared on a separate sheet. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm) or provide crop marks. Each illustration must be labelled with its number and the first author’s name. b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi. Figure files must not be embedded in a document file but submitted separately (see detailed instructions at Online Submission Instruction).
Color Illustrations
Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.
Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 760.00 per page.
References
In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as ‘unpublished data’ and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. (Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997;336:309–315 www.icmje.org)
|
Examples
(a) Papers published in periodicals:
Sun J, Koto H, Chung KF: Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int Arch Allergy Immunol 1997;112:191–195.
(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.
(c) Monographs:
Matthews DE, Farewell VT: Using and Understanding Medical Statistics,
ed 3, revised. Basel, Karger, 1996.
(d) Edited books:
Parren PWHI, Burton DR: Antibodies against HIV-1 from phage display libraries: Mapping of an immune response and progress towards antiviral immunotherapy; in Capra JD (ed): Antibody Engineering. Chem Immunol. Basel, Karger, 1997, vol 65, pp 18–56.
|
Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.
SI Units
Since the United States of America and other countries outside Europe where ‘Respiration’ is read have not accepted the SI System, authors using SI Units should add the conventional units in parentheses, for example: p02 = 10 kPa (75 mm Hg).
Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org
Author's ChoiceTM
Karger's Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.Karger.com. The option is available for a one-time fee of CHF 2,750.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
NIH-Funded Research
The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date. As a service to authors, Karger submits the final version of your article on your behalf to PubMed Central. For those selecting our premium Author's ChoiceTM service, we will send your article immediately upon publishing, accelerating the accessibility of your work without the usual embargo. More details on NIH's Public Access Policy is available here.
Self-Archiving
Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. final draft post-refereeing) on their personal or institution's servers, provided the following conditions are met: Articles may not be used for commercial purposes, must be linked to the publisher's version, and must acknowledge the publisher's copyright. Authors selecting Karger's Author's ChoiceTM feature, however, are also permitted to archive the final, published version of their article, which includes copyediting and design improvements as well as citation links.
Page Charges
There are no page charges for papers of 4 or fewer printed pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 310.00. The allotted size of a paper is equal to approx. 12 manuscript pages (including tables, illustrations and references).
Proofs
Unless indicated otherwise, proofs are sent to the first-named author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer’s errors, are charged to the author. No page proofs are supplied.
Reprints
Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.
Financial Disclosure and Conflicts of Interest
Authors must disclose any and all financial involvement in any organization with a direct financial interest in the subject discussed in the submitted manuscript.
Any conflict of interest for a given manuscript must be dealt with according to the statement of the International Committee of Medical Journal Editors (the ‘Vancouver Group’) (Lancet 1993;341:742).
Further Information
For any further details please contact Respiration's Editorial Office.
|
|
|
| Search in this journal
|
|
|
|
For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|
Online Manuscript Submission
Guidelines
